Pierre Gholam MD

@livermd.bsky.social

3 years ago

@EASLedu @EASLnews improvement in MRE and #VCTE at both 100 and 80 mg doses of #resmetirom limitations include low fibrosis burden in participants. AE included diarrhea and nausea mostly in the first 12 weeks. #ILC2022